Should You Add RIGL Stock to Your Portfolio Pre-Q4 Earnings?

Rigel Pharmaceuticals, Inc. (RIGL) is set to report its fourth-quarter and full-year 2024 earnings on March 4. The Zacks Consensus Estimate for sales and earnings is pegged at $57.57 million and 42 cents per share, respectively.The Zacks Consensus Estimate for 2024 earnings per share (EPS) has increased to 22 cents from 17 cents over the past 60 days. The EPS estimate for 2025 has also jumped 13 cents to$1.05.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.RIGL Estimate MovementImage ...